Search results: Sage Journals

Open accessReview articleFirst published 2026

Impact of Dolutegravir-Based Antiretroviral Therapy on Viral Load Suppression and Uptake of DTG-Based Regimen Among Pediatric HIV Patients in Africa: A Systematic Review and Meta-Analysis

Desalegn Mitiku Kidie, Abraham Dessie Gessesse, Jenberu Mekurianew Kelkay [...]

Journal of the International Association of Providers of AIDS Care (JIAPAC)

Open accessResearch articleFirst published 2024

Metabolic Syndrome Among People Living With HIV on Dolutegravir and Efavirenz-Based Antiretroviral Therapy in Ethiopia: A Comparative Cross-Sectional Study

Mohammed Jemal, Baye Ashenef, Deresse Sinamaw [...]

Journal of the International Association of Providers of AIDS Care (JIAPAC)

Open accessResearch articleFirst published 2025

Role of Dolutegravir-based antiretroviral treatment in achieving an undetectable HIV-1 viral load among women attending prevention of mother-to-child transmission clinics in Addis Ababa,Ethiopia

Belete Woldesemayat, Yimam Getaneh, Sisay Adane [...]

Sage Open Medicine

Open accessReview articleFirst published January, 2020

Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine,a Two-Drug Antiretroviral Therapy for HIV-1 Infection

Marta Boffito, Laura Waters, Pedro Cahn [...]

AIDS Research and Human Retroviruses

Open accessResearch articleFirst published 2022

Adherence,Effectiveness and Safety of Dolutegravir Based Antiretroviral Regimens among HIV Infected Children and Adolescents in Tanzania

Ritah F. Mutagonda, Hamu J. Mlyuka, Betty A. Maganda [...]

Journal of the International Association of Providers of AIDS Care (JIAPAC)

Restricted accessResearch articleFirst published February, 2019

Abacavir/lamivudine/dolutegravir single tablet regimen in patients with human immunodeficiency virus and end-stage renal disease on hemodialysis

Sarah M Michienzi, Christopher A Schriever, Melissa E Badowski

International Journal of STD & AIDS

Free accessAnnouncementFirst published January, 2019

A Comparison between two Dolutegravir-Based two-drug Regimens as Switch Strategies in a Multicentre Cohort of HIV-1-Infected Patients

Arturo Ciccullo, Gianmaria Baldin, Amedeo Capetti [...]

Antiviral Therapy

Restricted accessResearch articleFirst published December, 2022

Changes in Inflammatory Biomarkers When Switching from Three-Drug Regimens to Dolutegravir Plus Lamivudine in People Living with HIV

Eisuke Adachi, Kazuhiko Ikeuchi, Michiko Koga [...]

AIDS Research and Human Retroviruses

Free accessResearch articleFirst published December, 2018

Psychiatric outcomes observed in patients living with HIV using six common core antiretrovirals in the Observational Pharmaco-Epidemiology Research and Analysis database

Ricky Hsu, Jennifer Fusco, Cassidy Henegar [...]

Therapeutic Advances in Drug Safety

Open accessResearch articleFirst published December, 2022

The risk of hyperglycemia associated with use of dolutegravir among adults living with HIV in Kampala,Uganda: A case-control study

Daphine Namara, Jeremy I Schwartz, Andrew K Tusubira [...]

International Journal of STD & AIDS

Open accessReview articleFirst published 2026

Impact of Dolutegravir-Based Antiretroviral Therapy on Viral Load Suppression and Uptake of DTG-Based Regimen Among Pediatric HIV Patients in Africa: A Systematic Review and Meta-Analysis

Desalegn Mitiku Kidie, Abraham Dessie Gessesse, Jenberu Mekurianew Kelkay [...]

Journal of the International Association of Providers of AIDS Care (JIAPAC)

Open accessResearch articleFirst published 2024

Metabolic Syndrome Among People Living With HIV on Dolutegravir and Efavirenz-Based Antiretroviral Therapy in Ethiopia: A Comparative Cross-Sectional Study

Mohammed Jemal, Baye Ashenef, Deresse Sinamaw [...]

Journal of the International Association of Providers of AIDS Care (JIAPAC)

Open accessResearch articleFirst published 2025

Role of Dolutegravir-based antiretroviral treatment in achieving an undetectable HIV-1 viral load among women attending prevention of mother-to-child transmission clinics in Addis Ababa,Ethiopia

Belete Woldesemayat, Yimam Getaneh, Sisay Adane [...]

Sage Open Medicine

Open accessReview articleFirst published January, 2020

Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine,a Two-Drug Antiretroviral Therapy for HIV-1 Infection

Marta Boffito, Laura Waters, Pedro Cahn [...]

AIDS Research and Human Retroviruses

Open accessResearch articleFirst published 2022

Adherence,Effectiveness and Safety of Dolutegravir Based Antiretroviral Regimens among HIV Infected Children and Adolescents in Tanzania

Ritah F. Mutagonda, Hamu J. Mlyuka, Betty A. Maganda [...]

Journal of the International Association of Providers of AIDS Care (JIAPAC)

Restricted accessResearch articleFirst published February, 2019

Abacavir/lamivudine/dolutegravir single tablet regimen in patients with human immunodeficiency virus and end-stage renal disease on hemodialysis

Sarah M Michienzi, Christopher A Schriever, Melissa E Badowski

International Journal of STD & AIDS

Free accessAnnouncementFirst published January, 2019

A Comparison between two Dolutegravir-Based two-drug Regimens as Switch Strategies in a Multicentre Cohort of HIV-1-Infected Patients

Arturo Ciccullo, Gianmaria Baldin, Amedeo Capetti [...]

Antiviral Therapy

Restricted accessResearch articleFirst published December, 2022

Changes in Inflammatory Biomarkers When Switching from Three-Drug Regimens to Dolutegravir Plus Lamivudine in People Living with HIV

Eisuke Adachi, Kazuhiko Ikeuchi, Michiko Koga [...]

AIDS Research and Human Retroviruses

Free accessResearch articleFirst published December, 2018

Psychiatric outcomes observed in patients living with HIV using six common core antiretrovirals in the Observational Pharmaco-Epidemiology Research and Analysis database

Ricky Hsu, Jennifer Fusco, Cassidy Henegar [...]

Therapeutic Advances in Drug Safety

Open accessResearch articleFirst published December, 2022

The risk of hyperglycemia associated with use of dolutegravir among adults living with HIV in Kampala,Uganda: A case-control study

Daphine Namara, Jeremy I Schwartz, Andrew K Tusubira [...]

International Journal of STD & AIDS